Using a uterine tourniquet during conservative management of placenta accreta to improve newborn APGAR
Official title: Impact of Using Tourniquet in Conservative Placenta Accrete Spectrum on Neonatal APGAR Score . A Randomized Controlled Trial .
Run by Kasr El Aini Hospital · NCT07412925 · Data updated 2026-11-12
This will try placing a tourniquet around the lower uterus during conservative management of placenta accreta in pregnant people (≥34 weeks, prior cesarean) to see if it improves newborn APGAR scores.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Kasr El Aini Hospital Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | April 30, 2025 |
| Main results expected | March 1, 2026 |
| Study ends | March 1, 2026 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07412925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant people aged 20–40 with a singleton fetus at or beyond 34 weeks, prior cesarean delivery, diagnosed placenta accreta spectrum and planned elective conservative management with preoperative hemoglobin ≥10 g/dL.
✕Probably not a fit
People with significant medical or pregnancy-associated disorders, uterine pathology, premature rupture of membranes, multifetal pregnancies, cases misdiagnosed intraoperatively, or those requiring immediate hysterectomy are unlikely to benefit from this conservative tourniquet approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol enrolls pregnant people with diagnosed placenta accreta spectrum (singleton pregnancies, age 20–40, gestation ≥34 weeks, prior cesarean) who are candidates for conservative management and elective delivery. At cesarean, a tourniquet is applied around the lower uterine segment as part of conservative placenta accreta management, with perioperative monitoring and standard obstetric care. The primary focus is on immediate neonatal APGAR scores and perioperative maternal outcomes related to bleeding and the need for additional procedures. The trial is conducted at Kasr Al Aini Hospitals, Faculty of Medicine, Cairo University.
Why it matters
Potential benefit: If successful, the approach could reduce maternal bleeding during conservative management and improve newborn immediate condition as measured by APGAR scores.
How similar studies have gone: Small case series and surgical reports suggest uterine tourniquets or similar vascular control methods can reduce bleeding, but high-quality randomized evidence for this specific approach in placenta accreta is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 20-40 years old. 2. Pregnancy of a singleton living fetus. 3. Gestational age: pregnancy completing 34 weeks or more. 4. Previous one or more cesarean delivery. 5. Current pregnancy complicated by Placena Accreta Spectrum Disorder candidate for conservative managment either total or partial Placenta Accreta. 6. Elective termination of pregnancy. (35-37 weeks) 7. Preoperative Hemoglobin ≥ 10 g/dl. Exclusion Criteria: * 1-Patients who refuse to participate in the study. 2-Women with history of a concomitant chronic or a pregnancy associated medical disorder eg. Gestational diabetes, hypertension, cardiac or renal disease. 3-Presence of a concomitant uterine pathology (eg. Uterine fibroid) 4-Premature rupture of membranes. 5-Cases misdiagnosed as placenta accreta by ultrasound preoperatively, and spontaneous full placental separation occurred intraoperative or as total/partial accreta and found to be focal accreta intraoperative. 6-Cases requiring preoperative blood transfusion. 7- Any fetal abnormality e.g IUGR or SGA
Where it's running
-
kasr Al Aini Hospitals , Faculty of medicine , Cairo University , Cairo
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Yassmine A Hamouda, MSC
- Email: yassmineamrabdelmegid@hotmail.com
- Phone: 00201001680580
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
-
Pregnant women weight-management support via an app and care model
Aims to try a smartphone-based weight-management program plus professional support for pregnant women to see if it helps manage gestational weight and promote healthy behaviors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.